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The inflammatory response is modulated by the concen-
tration of soluble mediators and the coordinated action of
different types of immune cells. Furthermore, basic and
clinical research has demonstrated that the immune response
is regulated by several factors such as: the chemical nature and
the concentration of antigen; the route of administration; the
cell type involved in the antigen presentation to their specific
lymphocytes; and the presence of antibodies and/or immune
complexes among other mechanisms.
More recently, it has been described that other signaling
molecules like neurotransmitters and hormones can also
modulate the immune response. Over time, this information
has enabled the elucidation of the role of immune cell prod-
ucts in physiological processes like sleep, memory, learning,
and pain, or in autoimmune and infective diseases, as well as
the mechanisms involved. Such evidence provides the oppor-
tunity for the development of novel therapeutic approaches
for diseases with deleterious immune and inflammatory
components. The papers presented in this special issue focus
on the leveraging knowledge of clinical and experimental
immunomodulation.
First, the reader can find seven experimental approaches
that analyze immunomodulation mediated by hormones,
neurotransmitters, cytokines, and antigens.Thework ofM.V.
Legorreta-Haquet et al. shows that prolactin in early stages of
B cells maturation process may promote the survival of self-
reactive clones in a murine model of lupus. T. Schaumann et
al. present results of anti-inflammatory effects of glycine in
gingival inflammation and encourage further research on the
utility of glycine in the prevention therapy of inflammatory
periodontitis. B. De´nes et al. share an interesting work
on experimental immunotherapy with a multicomponent
vaccine containing a cholera toxin B subunit-autoantigen
fusion protein for restoration of euglycemia and immuno-
logical homeostasis in NOD mice. F. Robledo-A´vila et al.
explored a novel therapeutic approach consisting in the
administration of murine dialyzable leukocyte extracts plus
a reduced, and therefore less toxic, dose of Amphotericin
B in a mouse model of systemic candidiasis. The approach
proved to be effective in reducing mortality, pathogen bur-
den, and tissue damage at the renal level. S. Mburu et al.
evaluated in vitro the modulation of LPS-induced CD4+ T
cell activation and apoptosis by antioxidants in cells from
untreated asymptomatic HIV infected participants. Their
results set the basis for the development of an adjuvant
therapy aimed to counteract the harmful effects of chronic
immune activation on CD4+ T cells. S. Dang et al. show
that LMW-HAmodulates papillary thyroid carcinoma (PTC)
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cell behavior via TLR-4 signaling providing examples of the
functional roles of CXCR7 in proliferation and migration.
Their data are elegantly complemented with the analysis of
TLR4 andCXCR7 expression in PTCclinical samples. Finally,
J. M. Calleja-Castillo et al. investigate the effect of deep
brain stimulation (DBS) at hypothalamic nucleus in Wistar
rats, over the circulating concentrations of corticosterone
and proinflammatory cytokines, detecting that the chronic
application of this therapy toWistar rats induces a significant
circulatory rise in inflammatory mediators and blocks HPA
axis activity. These results suggest that immunity might be
altered in patients who are treated with DBS and provide the
basis for the development of strategies to prevent immunity-
related secondary effects of DBS.
Regarding the clinical approaches of immunomodula-
tion, three works are also included. The first one, from
N. Valero-Pacheco et al., analyzes the expression of PD-
L1 on T cells in patients infected with the influenza virus
A(H1N1)pdm09 and its impact on T cell responses. The
second one, from J. Galicia-Carreo´n et al., studies the context
of the unbalanced immunological mechanisms underlying
the development of allergic conjunctivitis by evaluating the
frequency of Tregs as well as cells expressing homing recep-
tors in peripheral blood frompatients.The third one, fromM.
E. Herna´ndez et al., presents the results of a clinical followup
of major depressive disorder (MDD) patients treated with
a combination of selective serotonin reuptake inhibitors
(SSRI) and human dialyzable leukocytes extract (hDLE)
as immunomodulator. The latter consists of small weight
peptides and has been used successfully as adjuvant therapy
in diverse infectious and deficient cell-immunity problems.
MDD patients present imbalances in neurotransmitter levels,
hormones such as cortisol, and cytokines that contribute to
the behavioral and immune disturbances observed in them.
This combined treatment efficiently restored the pro- and
anti-inflammatory cytokine balance and cortisol levels when
compared with patients treated only with SSRI. This study
constitutes the first report of a clinical assay that analyzes the
effects of immunotherapy in MDD.
This special issue also includes two reports of experi-
mental techniques that allow the assessment of immunomod-
ulation. The work of I. Lima Siman et al. evaluated the
serum levels of allergen-specific IgG antibodies from atopic
patients.The authors conclude that this laboratory test would
help specialists to follow up patients under immunother-
apy. The report by M. C. Jime´nez-Mart´ınez et al. shows
an experimental technique to identify NnTreg lymphocytes
by staining them with Amaranthus leucocarpus lectin and
posterior FACS.
Last but not least, this issue presents four revisions on a
broad range of topics. N. Deckx et al. focus on multiple scle-
rosis and discuss the influence of neuroendocrine immune
system over the susceptibility and severity of autoimmune
diseases, as well as new therapeutic approaches for the
treatment of this kind of diseases. R. Cabezo´n and D.
Benitez-Rı´bas review the participation of different dendritic
cells (DCs) subsets and their role in inflammatory bowel
disease and present preclinical studies performed in animal
models describing the recent characterization of tol-DCs
from Crohn’s disease patients. G. A. Toledo-Ibarra et al.
describe some aspects of the immunity of fish and its con-
nections with cholinergic system, highlighting the possibility
that bidirectional communication between the nervous and
immune systems exists in lower vertebrates as well as during
evolution of immune system. G. Hurtado-Alvarado et al.
present an extensive review focused on the relationship
between inflammation and inflammatory markers as well as
sleep and sleep loss.
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